Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ACTRN12626000453381) titled 'INtentional PreOperative WEight loss for patients with obesity diagnosed with Resectable GastroIntestinal cancer (INPOWER-GI)' on April 10.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Safety/efficacy
Primary Sponsor: Monash Health
Condition:
obesity
gastrointestinal cancer
obesity
gastrointestinal cancer
Metabolic and Endocrine - Other metabolic disorders
Cancer - Stomach
Cancer - Bowel - Anal
Cancer - Biliary tree (gall bladder and bile duct)
Cancer - Liver
Cancer - Oesophageal...